逼尿肌活动低下对钬激光前列腺剜除术手术结局的影响
这项前瞻性数据库研究纳入2018年1月至2022年12月接受钬激光前列腺剜除术的良性前列腺增生患者689例,按膀胱收缩力指数分为逼尿肌活动低下组(364例,指数<100)和非逼尿肌活动低下组(325例,指数≥100)。两组术后客观和主观指标均显著改善,逼尿肌活动低下组术后最大尿流率较低、术后6个月总国际前列腺症状评分较高,但手术并发症无显著差异,逼尿肌活动低下组总体满意度高。
要点
- 逼尿肌活动低下组与非逼尿肌活动低下组术后客观和主观指标均显著改善。
- 逼尿肌活动低下组术后最大尿流率低于非逼尿肌活动低下组。
- 术后6个月逼尿肌活动低下组总国际前列腺症状评分高于非逼尿肌活动低下组。
核心结论
- 中期结果显示,合并逼尿肌活动低下的良性前列腺增生患者接受钬激光前列腺剜除术后的临床结局与非逼尿肌活动低下患者相比差异很小,逼尿肌活动低下组总体满意度高。
研究设计与样本
- 前瞻性数据库研究,纳入2018年1月至2022年12月接受钬激光前列腺剜除术的良性前列腺增生患者689例,平均(标准差)年龄69.8(7.1)岁。
- 按膀胱收缩力指数分为逼尿肌活动低下组(指数<100,364例,52.8%)和非逼尿肌活动低下组(指数≥100,325例,47.2%)。
主要发现
- 非逼尿肌活动低下组平均(标准差)膀胱收缩力指数为123.4(21.4),逼尿肌活动低下组为78.6(14.2)。
- 两组术后最大尿流率和残余尿量均显著改善;逼尿肌活动低下组术后最大尿流率低于非逼尿肌活动低下组。
- 术后6个月逼尿肌活动低下组总国际前列腺症状评分高于非逼尿肌活动低下组。
- 两组手术并发症无显著差异。
- 术后6个月,逼尿肌活动低下组对治疗满意者90.5%、非逼尿肌活动低下组95.2%;症状改善者分别为95.9%和100.0%;愿意再次手术者分别为95.9%和97.9%;治疗满意度问题和再次手术意愿问题的组间差异无统计学意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effect of detrusor underactivity (DUA) on the postoperative outcomes of holmium laser enucleation of the prostate (HoLEP) in patients with benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: Patients with BPH who underwent HoLEP between January 2018 and December 2022 were enrolled in this prospective database study. Patients were divided into DUA (bladder contractility index [BCI] <100) and non-DUA (BCI ≥100) groups. Objective (maximum urinary flow rate [Qmax], post-void residual urine volume [PVR]) and subjective outcomes (International Prostate Symptom Score [IPSS], Overactive Bladder Symptom Score [OABSS], satisfaction with treatment question [STQ], overall response assessment [ORA], and willingness to undergo surgery question [WUSQ]) were compared between the two groups before surgery, and at 3 and 6 months after HoLEP. RESULTS: A total of 689 patients, with a mean (standard deviation [SD]) age of 69.8 (7.1) years, were enrolled. The mean (SD) BCI in the non-DUA (325 [47.2%]) and DUA (364 [52.8%]) groups was 123.4 (21.4) and 78.6 (14.2), respectively. Both objective (Qmax and PVR) and subjective (IPSS, IPSS-quality of life, and OABSS) outcomes after surgery significantly improved in both groups. The Qmax was lower in the DUA than in the non-DUA group postoperatively. At 6 months postoperatively, the total IPSS was higher in the DUA than in the non-DUA group. There were no significant differences in surgical complications between the two groups. Responses to the STQ, ORA, and WUSQ at 6 months postoperatively demonstrated that the patients were satisfied with the surgery (90.5% in the DUA group; 95.2% in the non-DUA group), their symptoms improved with surgery (95.9% in the DUA group; 100.0% in the non-DUA group), and they were willing to undergo surgery again (95.9% in the DUA group; 97.9% in the non-DUA group). There were no significant differences in the responses to the STQ and WUSQ between the two groups. CONCLUSION: Our midterm results demonstrated that patients with BPH and DUA showed minimal differences in clinical outcomes after HoLEP compared to those without DUA. The overall satisfaction was high in the DUA group.
引用
- Jeong HJ, Lee H, Choo MS, et al. Effect of detrusor underactivity on surgical outcomes of holmium laser enucleation of the prostate. BJU Int. 2024. PMID: 38520132. doi:10.1111/bju.16346
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。